These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11744342)

  • 41. Physicochemical stability of parenteral nutrition supplied as all-in-one for neonates.
    Skouroliakou M; Matthaiou C; Chiou A; Panagiotakos D; Gounaris A; Nunn T; Andrikopoulos N
    JPEN J Parenter Enteral Nutr; 2008; 32(2):201-9. PubMed ID: 18407915
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of acceptance criteria for particulate limits for small-volume parenteral products.
    Tsuji K; Lewis AR
    J Pharm Sci; 1978 Jan; 67(1):50-5. PubMed ID: 619115
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Parenteral amino acid intakes in critically ill children: a matter of convenience.
    Verbruggen S; Sy J; Arrivillaga A; Joosten K; van Goudoever J; Castillo L
    JPEN J Parenter Enteral Nutr; 2010; 34(3):329-40. PubMed ID: 20093426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physicochemical stability of an admixture for total parenteral nutrition.
    Segall A; Vitale M; Hormaechea F; Disalvo A; Menéndez AM; Rusi F; Montemerlo H; Pizzorno MT
    Pharmazie; 2001 Nov; 56(11):899-900. PubMed ID: 11817181
    [No Abstract]   [Full Text] [Related]  

  • 45. Selenium stability in total parenteral nutrition solutions.
    Postaire E; Anglade P
    JPEN J Parenter Enteral Nutr; 1990; 14(2):223-4. PubMed ID: 2112633
    [No Abstract]   [Full Text] [Related]  

  • 46. Impact of particulate contamination in crystalloid cardioplegic solutions: studies by scanning and transmission electron microscopy.
    Hellinger A; Piotrowski J; Konerding MA; Burchard WG; Doetsch N; Peitgen K; Erhard J; Reidemeister JC
    Thorac Cardiovasc Surg; 1997 Feb; 45(1):20-6. PubMed ID: 9089970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Physicochemical stability of individualized parenteral nutrition in neonatal period].
    Lombardi J; Semama DS
    Ann Pharm Fr; 2018 Mar; 76(2):154-162. PubMed ID: 29395015
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Bacteriological study of solutions for parenteral nutrition].
    López Vílchez A; Ruiz Jiménez J; Huete Navarro M
    Rev Enferm; 1984 Sep; 7(72-73):90-1. PubMed ID: 6435231
    [No Abstract]   [Full Text] [Related]  

  • 49. Particles in intravenous solutions: a review.
    Thomas WH; Lee YK
    N Z Med J; 1974 Aug; 80(522):170-8. PubMed ID: 4608302
    [No Abstract]   [Full Text] [Related]  

  • 50. [Stability and sterility of parenteral nutrition admixture for patients home care manufactured by the automated compounding BAXA® EM 2400].
    Chappuy L; Charroin C; Vételé F; Durand T; Quessada T; Klotz MC; Pirot F; Bréant V; Aulagner G
    Ann Pharm Fr; 2013 Nov; 71(6):401-9. PubMed ID: 24206592
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Particulate matter of particular interest.
    Duma RJ
    Ann Intern Med; 1973 Jan; 78(1):146-7. PubMed ID: 4629864
    [No Abstract]   [Full Text] [Related]  

  • 52. Particulate and microbial contamination in in-use admixed intravenous infusions.
    Yorioka K; Oie S; Oomaki M; Imamura A; Kamiya A
    Biol Pharm Bull; 2006 Nov; 29(11):2321-3. PubMed ID: 17077539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro analysis of overall particulate contamination exposure during multidrug IV therapy: impact of infusion sets.
    Perez M; Décaudin B; Abou Chahla W; Nelken B; Barthélémy C; Lebuffe G; Odou P
    Pediatr Blood Cancer; 2015 Jun; 62(6):1042-7. PubMed ID: 25755136
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Calcium and phosphates compatibilities in parenteral nutrition admixtures].
    Driss Chaieb S; Sfar S; Chaumeil JC
    Tunis Med; 2006 Nov; 84(11):677-82. PubMed ID: 17294890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Quantitative analysis of particulate matter in infusion solutions, administration sets and additives (author's transl)].
    Ahnefeld FW; Klaus E
    Anaesthesist; 1977 Aug; 26(8):476-84. PubMed ID: 907081
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Study of particulate matter in carbenicillin disodium using scanning electron microscopy and microbeam x-ray spectrography.
    Bollinger RO; Preuss AM; McClain PR; Hill WT
    Am J Hosp Pharm; 1978 Mar; 35(3):312-7. PubMed ID: 626212
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
    Trissel LA; Gilbert DL; Martinez JF; Baker MB; Walter WV; Mirtallo JM
    JPEN J Parenter Enteral Nutr; 1999; 23(2):67-74. PubMed ID: 10081995
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aluminum contamination of parenteral nutrition fluids.
    Mirtallo JM
    JPEN J Parenter Enteral Nutr; 2010; 34(3):346-7. PubMed ID: 20467017
    [No Abstract]   [Full Text] [Related]  

  • 59. The aluminum content of parenteral solutions: current status.
    Klein GL
    Nutr Rev; 1991 Mar; 49(3):74-9. PubMed ID: 1905389
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aluminum contamination of neonatal parenteral nutrient solutions and additives.
    Mouser JF; Wu AH; Herson VC
    Am J Health Syst Pharm; 1998 May; 55(10):1071-2. PubMed ID: 9606461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.